Literature DB >> 23968600

Canadian pharmacare: looking back, looking forward.

Steven G Morgan1, Jamie R Daw.   

Abstract

Despite Canadians' pride in medicare and the values underpinning it, the system is conspicuously incomplete. Universal public health insurance in Canada ends as soon as a patient is handed a prescription to fill; yet prescription drugs are the second largest component of health system costs. We look back at key moments in Canadian healthcare history that shaped our pharmacare system - or lack thereof. We look forward to changes in demography and technology that will increase the need for pharmacare reform in the near future. We conclude that meaningful public engagement in pharmacare design may generate the clarity of goals and level of political support needed should windows of policy opportunity open again.
Copyright © 2012 Longwoods Publishing.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23968600      PMCID: PMC3430151     

Source DB:  PubMed          Journal:  Healthc Policy        ISSN: 1715-6572


  18 in total

1.  Beneficiary cost sharing under Canadian provincial prescription drug benefit programs: history and assessment.

Authors:  Paul Grootendorst
Journal:  Can J Clin Pharmacol       Date:  2002

2.  To build a wooden horse...integrating drugs into the public health system.

Authors:  Pierre-Gerlier Forest
Journal:  Healthc Pap       Date:  2004

3.  Post-Romanow pharmacare: last-dollar first...first-dollar lost?

Authors:  Steven G Morgan; Donald J Willison
Journal:  Healthc Pap       Date:  2004

4.  Ivacaftor.

Authors:  Pamela B Davis; Uma Yasothan; Peter Kirkpatrick
Journal:  Nat Rev Drug Discov       Date:  2012-04-30       Impact factor: 84.694

5.  Stitching the gaps in the Canadian public drug coverage patchwork?: a review of provincial pharmacare policy changes from 2000 to 2010.

Authors:  Jamie R Daw; Steven G Morgan
Journal:  Health Policy       Date:  2011-10-05       Impact factor: 2.980

6.  Public/private partnerships for prescription drug coverage: policy formulation and outcomes in Quebec's universal drug insurance program, with comparisons to the Medicare prescription drug program in the United States.

Authors:  Marie-Pascale Pomey; Pierre-Gerlier Forest; Howard A Palley; Elisabeth Martin
Journal:  Milbank Q       Date:  2007-09       Impact factor: 4.911

7.  Prescription drug spending trends in the United States: looking beyond the turning point.

Authors:  Murray Aitken; Ernst R Berndt; David M Cutler
Journal:  Health Aff (Millwood)       Date:  2008-12-16       Impact factor: 6.301

8.  The effect of pharmaceutical patent term length on research and development and drug expenditures in Canada.

Authors:  Paul Grootendorst; Livio Di Matteo
Journal:  Healthc Policy       Date:  2007-02

9.  The effect of cost on adherence to prescription medications in Canada.

Authors:  Michael R Law; Lucy Cheng; Irfan A Dhalla; Deborah Heard; Steven G Morgan
Journal:  CMAJ       Date:  2012-01-16       Impact factor: 8.262

10.  Pharmaceuticals, patents, and politics: Canada and Bill C-22.

Authors:  J Lexchin
Journal:  Int J Health Serv       Date:  1993       Impact factor: 1.663

View more
  9 in total

1.  Should national pharmacare apply a value-based insurance design?

Authors:  Kai Yeung; Steven G Morgan
Journal:  CMAJ       Date:  2019-07-22       Impact factor: 8.262

2.  Introduction to the Special Issue: Precarious Solidarity-Preferential Access in Canadian Health Care.

Authors:  Lynette Reid
Journal:  Health Care Anal       Date:  2017-06

3.  Medication access via hospital admission.

Authors:  Annie Wang; Trudo Lemmens; Navindra Persaud
Journal:  Can Fam Physician       Date:  2017-05       Impact factor: 3.275

4.  Community members co-designing a trial of medication access.

Authors:  Nav Persaud; Marleane Davidson; Diane Charter
Journal:  CMAJ       Date:  2018-11-07       Impact factor: 8.262

5.  National pharmacare: Time to move forward.

Authors:  Leila Salehi
Journal:  Can Fam Physician       Date:  2016-07       Impact factor: 3.275

6.  [Assurance-médicaments nationale: Le moment d'aller de l'avant].

Authors:  Leila Salehi
Journal:  Can Fam Physician       Date:  2016-07       Impact factor: 3.275

Review 7.  Evaluating the effects of Quebec's private-public drug insurance system.

Authors:  Steven G Morgan; Marc-André Gagnon; Mathieu Charbonneau; Alain Vadeboncoeur
Journal:  CMAJ       Date:  2017-10-10       Impact factor: 8.262

8.  After More Than 50 Years, Pharmacare (and Dental Care) are Coming to Canada.

Authors:  Joel Lexchin
Journal:  Int J Health Serv       Date:  2022-05-09       Impact factor: 1.851

9.  It Won't Be Easy: How to Make Universal Pharmacare Work in Canada.

Authors:  Steven Lewis
Journal:  Int J Health Policy Manag       Date:  2020-01-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.